ClinicalTrials.Veeva

Menu

Treatment of Cutaneous Ulcers With a Novel Biological Dressing

L

Laval University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Venous Ulcers

Treatments

Device: self assembled skin substitute (SASS)

Study type

Interventional

Funder types

Other

Identifiers

NCT00207818
LOEX 005
29478 Health Canada

Details and patient eligibility

About

The aim of the study is to evaluate the effect of a biological dressing on the healing process of venous ulcers. The dressing is a reconstructed skin substitute made with the patients own cells.

Full description

The hypothesis of this trial is that the cutaneous model SASS, a dermal epidermal skin substitute, created by the LOEX could be as high-performant, or even better, than the one's already existent in North America for the wound care. We anticipate showing on 6 patients that ulcer that did not close with conventional treatment, will heal or at least improve with this treatment.

Enrollment

6 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Men or women from 18 to 85 years old
  2. Have a venous ulcer or a mixed ulcer

Exclusion criteria

Diabetes Mental deficiency Hepatitis holder (A-B-C) HIV positive Pregnancy or lactation Corticosteroids therapy Radiotherapy Chemotherapy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems